This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Johnson & Johnson Enterprise Innovation Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Christopher Scott Stevenson: Innovator in Lung Cancer Risk Prediction
Introduction
Christopher Scott Stevenson is a renowned inventor located in West Sussex, GB, recognized for his significant contributions to the field of medical innovation. With a total of three patents to his name, Stevenson has made remarkable strides in developing technologies for predicting lung cancer risks.
Latest Patents
Christopher's latest patents center around advanced systems and methods for predicting the risk of future lung cancer. These inventions utilize risk prediction models that are trained and deployed to analyze images, such as computed tomography scans. The models aim to predict the current or future risk of lung cancer for one or more subjects by basing predictions on both nodule-specific and non-nodule-specific features. These models, which provide insights across various time horizons, are essential for developing preventive therapies for lung cancer and facilitating the enrichment of clinical trials.
Career Highlights
Stevenson's career has been marked by his affiliation with Johnson & Johnson Enterprise Innovation Inc., where his expertise in medical technologies has flourished. His innovative approach and commitment to enhancing cancer prediction methodologies have established him as a valuable asset in the healthcare sector.
Collaborations
Working alongside prominent colleagues such as George R. Washko and Samuel Yoffe Ash, Stevenson has engaged in collaborative efforts that have further driven innovation in the field of medical imaging and risk assessment. These partnerships have been integral to the development of his patented technologies.
Conclusion
Christopher Scott Stevenson continues to influence the realm of medical innovation with his groundbreaking work in lung cancer risk prediction. His patents reflect a dedication to improving patient outcomes and shaping the future of preventive healthcare. As he moves forward, his contributions are expected to play a pivotal role in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile